A drug used to treat multiple sclerosis could help reduce asthma attacks caused by the common cold virus. A team from the University of Southampton found the cold virus was able to replicate at much higher levels in the lung cells of asthma patients. But this replication was largely blocked in the laboratory when the cells were exposed to a form of the anti-MS drug interferon-B. Details are published in the Journal of Experimental Medicine.
